Connect
MJA
MJA

Pharmaceutical preparations

Letters

National guidelines for the management of absolute cardiovascular disease risk

Christopher J O’Callaghan, Pei Rong and Min Y Goh

Med J Aust 2014; 200 (8): 454-456

Research

Multidrug-resistant tuberculosis in Western Australia, 1998–2012

Joshua R Francis, Christopher C Blyth, Sarah Colby, Joanna M Fagan and Justin Waring

Med J Aust 2014; 200 (6): 328-332 Free

Letters

Inadvertent dispensing of Coumadin instead of Coversyl

Alexander M Owen and Sara L Hungerford

Med J Aust 2014; 200 (4): 204-205

Reflections / History

A functional dependence? A social history of the medical use of morphine in Australia

Matthew Grant, Jennifer Philip and Anna Ugalde

Med J Aust 2014; 200 (4): 230-232

Letters

Acute myopericarditis following intravenous zoledronic acid for the treatment of Paget’s disease

Monique R Watts, Andris H Ellims and David S Eccleston

Med J Aust 2014; 200 (3): 150

Letters

Psychotropics and challenging behaviour in people with an intellectual disability

Niki S Edwards, William Alexander and Allyson Mutch

Med J Aust 2014; 200 (8): 456

Letters

Pharmacometrics: an underused resource in Australian clinical research

Vidya Perera, Michael J Dolton, Andrew J McLachlan, Vaughan J Carr and Richard O Day

Med J Aust 2014; 200 (2): 82-83

Editorials

Off-label prescribing

J Paul Seale

Med J Aust 2014; 200 (2): 65

Editorials

Reducing off-label prescribing in psychiatry

Ian B Hickie

Med J Aust 2014; 200 (2): 65-66

Letters

Systematic postmarketing surveillance needed for misused psychoactive pharmaceutical drugs

Steven Moylan

Med J Aust 2013; 199 (11): 746-747

Letters

Systematic postmarketing surveillance needed for misused psychoactive pharmaceutical drugs

Angela C Rintoul and Malcolm D H Dobbin

Med J Aust 2013; 199 (11): 747

Letters

Inadvertent dispensing of Coumadin instead of Coversyl

Duncan P Carradice and Ellen L Maxwell

Med J Aust 2013; 199 (11): 750

Letters

Systematic postmarketing surveillance needed for misused psychoactive pharmaceutical drugs

Tracy W Soh

Med J Aust 2013; 199 (11): 746

Letters

Sotalol-associated cardiogenic shock in a patient with asymptomatic transient rate-related cardiomyopathy

Simon D Leslie

Med J Aust 2013; 199 (10): 658-659

Letters

Psychotropic medication in pregnancy

Roisin N Worsley, Heather Gilbert and Jayashri Kulkarni

Med J Aust 2013; 199 (10): 661

Research

Low awareness of adverse drug reaction reporting systems: a consumer survey

Jane Robertson and David A Newby

Med J Aust 2013; 199 (10): 684-686 Free

Case reports

Pregabalin-associated rhabdomyolysis

Roshan Gunathilake, Laura E Boyce and Anne T Knight

Med J Aust 2013; 199 (9): 624-625 Free

Supplement – Clinical Focus

Pharmacological treatment approaches to difficult-to-treat depression

Herng-Nieng Chan, Philip B Mitchell, Colleen K A Loo and Samuel B Harvey

Med J Aust 2013; 199 (6): S44-S47 Free

Case reports

Khat-associated hepatitis

Malcolm P Forbes, Ashok S Raj, Jennifer Martin, Guy Lampe and Elizabeth E Powell

Med J Aust 2013; 199 (7): 498-499 Free

Perspectives

The after-life of drugs: a responsible care initiative for reducing their environmental impact

Peter M J Fisher, David A Smith and Peter J Collignon

Med J Aust 2013; 199 (6): 388-390 Free

Letters

Vitamin D and health in adults in Australia and New Zealand

Bettina Douglas

Med J Aust 2013; 199 (6): 394

Letters

Vitamin D and health in adults in Australia and New Zealand

Caryl A Nowson and Rebecca S Mason

Med J Aust 2013; 199 (6): 394

Letters

Severe symptomatic hypocalcaemia following a single dose of denosumab

Jennifer M McLachlan, Gavin M Marx and Margaret Bridgman

Med J Aust 2013; 199 (4): 242-243

For debate

Trials and tribulations in the removal of dextropropoxyphene from the Australian Register of Therapeutic Goods

Nick A Buckley and Thomas A Faunce

Med J Aust 2013; 199 (4): 257-260 Free

Editorials

How can we improve access to new (and old) antibiotics in Australia?

Allen C Cheng and Roger L Nation

Med J Aust 2013; 199 (2): 81-82